Key risks of combining berberine and semaglutide include: Low blood sugar (hypoglycemia), particularly if you also use insulin or sulfonylureas Worsening GI symptoms such as nausea, cramping, bloating, diarrhea, or constipation Drug interactions from berberines effects on liver enzymes, which can change levels of other prescriptions These risks are the reason a clinician should review your full situation before you start the combo
Nausea occurs but is usually manageable
Our peptides are lyophilized (freeze-dried), making them shelf-stable for many weeks at room temperature
The radiation protection regulations from the International Commission for Radiological Protection (ICRP) set the limit for occupational exposure to 20 mSv per year of effective dose, averaged over a defined period of 5 years (100 mSv in 5 year), with no yearly dose exceeding 50 mSv (200)
Together, these peptides represent chemically stable, low-molecular-weight signaling molecules suitable for experimental use in cellular and preclinical research systems